Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn
NCT01718639
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
41
Enrollment
INDUSTRY
Sponsor class
Conditions
Postprandial Heartburn
Interventions
DEVICE:
IQP-LH-101 tablet
DEVICE:
IQP-LH-101 liquid
OTHER:
Placebo
Sponsor
InQpharm Group